MedTrace Logo

Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

NCT03339388 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-04-17

No results posted yet for this study

Summary

This is a single arm, multi-center study to assess the safety and efficacy of a form of extracorporeal lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.

Conditions

  • Urinary Stone

Interventions

DEVICE

Enhanced Lithotripsy System

Stone treatment with the Enhanced Lithotripsy System

Sponsors & Collaborators

  • Avvio Medical

    lead INDUSTRY

Principal Investigators

  • Damien M Bolton, MD, MBBS · Austin Hospital, Melbourne Australia

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-08
Primary Completion
2018-07-10
Completion
2022-10-05
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03339388 on ClinicalTrials.gov